B
Bernward Lauer
Researcher at Leipzig University
Publications - 148
Citations - 4962
Bernward Lauer is an academic researcher from Leipzig University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 28, co-authored 144 publications receiving 4207 citations.
Papers
More filters
Journal ArticleDOI
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Antoinette de Waha,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Bernward Lauer,Michael Böhm,Henning Ebelt,Steffen Schneider,Karl Werdan,Gerhard Schuler +19 more
TL;DR: In patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, IABP did not reduce 12 month all-cause mortality.
Journal ArticleDOI
Cardiac Troponin T in Patients With Clinically Suspected Myocarditis
Bernward Lauer,Christoph Niederau,Uwe Kühl,Mira Schannwell,Matthias Pauschinger,Bodo Eckhard Strauer,Heinz-Peter Schultheiss +6 more
TL;DR: Measurement of serum levels of cTnT provides evidence of myocyte injury in patients with clinically suspected myocarditis more sensitively than does conventional determination of cardiac enzyme levels.
Journal ArticleDOI
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Gerald S. Werner,Victoria Martin-Yuste,David Hildick-Smith,Nicolas Boudou,Georgios Sianos,Valery Gelev,José Ramón Rumoroso,Andrejs Erglis,Evald Høj Christiansen,Javier Escaned,Carlo Di Mario,Thomas Hovasse,Luis Teruel,Alexander Bufe,Bernward Lauer,Kris Bogaerts,Javier Goicolea,James C. Spratt,Anthony H. Gershlick,Alfredo R. Galassi,Yves Louvard,Eurocto trial investigators +21 more
TL;DR: Percutaneous coronary intervention leads to a significant improvement of the health status in patients with stable angina and a CTO as compared with OMT alone.
Journal ArticleDOI
Reversal of Cardiogenic Shock by Percutaneous Left Atrial-to-Femoral Arterial Bypass Assistance
TL;DR: A newly developed percutaneous left ventricular assist device (VAD) is implanted in 18 consecutive patients who had cardiogenic shock after myocardial infarction to offer effective treatment for these patients by providing active circulatory support.
Journal ArticleDOI
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Raban Jeger,Ahmed Farah,Marc-Alexander Ohlow,Norman Mangner,Norman Mangner,Sven Möbius-Winkler,Gregor Leibundgut,Daniel Weilenmann,Jochen Wöhrle,Stefan Richter,Matthias Schreiber,Felix Mahfoud,Axel Linke,Axel Linke,Frank-Peter Stephan,Christian Mueller,Peter Rickenbacher,Michael Coslovsky,Nicole Gilgen,Stefan Osswald,Christoph Kaiser,Bruno Scheller,Peter Buser,Michael Kühne,Michael J. Zellweger,Christian Sticherling,Bastian Wein,Raphael Twerenbold,Gregor Fahrni,Björn Plicht,Berthold Struck,Ismet Önal,Bodo Cremers,Yvonne P. Clever,Sebastian Ewen,Stephan Schirmer,Michael Böhm,Andreas Wagner,Bernward Lauer,Georg Stachel,Robert Höllriegel,Ephraim B. Winzer,Hans Rickli,Peter Ammann,Philipp Haager,Lukas Trachsel,Lucas Joerg,Dominique Nüssli,Hans Roelli,Micha T. Maeder,Franziska Rohner,Sinisa Markovic,Rima Paliskyte,Dominik Buckert,Belal Awad,Paul Erne,Peiman Jamshidi,Florim Cuculi,Ioannis Kapos,Stefan Toggweiler,Florian Riede,Tudor Constantin Pörner,Karsten Lenk,Michel Noutsias,Ralf Surber,Gudrun Dannberg,Markus Franz,Sylvia Otto,Robert Zweiker,Ella Niederl,Sabine Perl,Burkert Pieske,Albrecht Schmidt,Olev Luha,Dirk von Lewinski,Florian Krackhardt,Behrouz Kherad,Timo Jerichow,Christian Butter,Michael Neuss,Grit Tambor,Frank Hölschermann,Leonhard Bruch,Sebastian Winkler,Corinna Lenz,Mirko Seidel,Boris Keweloh,Alexandra Röttgen,Steffen Bohl,Alexander Wolf,Andreas Hoffmann +90 more
TL;DR: In small native coronary artery disease, DCB was non-inferior to DES regarding MACE up to 12 months, with similar event rates for both treatment groups.